Drugs discovery services


High Content Screening services for drug discovery


Fluofarma provides High Content Screening services for drug discovery from large-scale primary screening to lead characterization. Our automated cell biology platform combines cell-based assays with large-scale analysis. Fluofarma proprietary technology allows a functional analysis of several molecular events simultaneously in single cells.

Fluofarma offers comprehensive services for drugs discovery:

  • Cell-based assays design and miniaturization
  • Large-scale screening from hit to lead in living cells
  • Functional characterization and mechanism of action studies
  • Testing of the predictive toxicity: cytotoxicity and genotoxicity

For more information on our drugs discovery services


If you need to have further details on our drugs discovery services, do not hesitate to contact us.







drugs discovery services

FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to compare and profile your anti-cancer drugs. Read more [+]